Prestige Consumer Healthcare (PBH) Operating Leases (2019 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Operating Leases came in at $24.5 million in Q4 2025, up 1.28% year-on-year from $24.2 million in Q4 2024, and up 22.76% quarter-over-quarter from $19.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Operating Leases (2019 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Operating Leases history runs 7 years deep, the most recent figure standing at $24.5 million for Q4 2025.
- On a quarterly basis, Operating Leases rose 1.28% year-over-year to $24.5 million in Q4 2025; TTM through Dec 2025 was $24.5 million, a 1.28% increase from a year earlier, with the FY2025 full-year figure at $22.7 million, up 201.97% from the prior year.
- Operating Leases rose to $24.5 million in Q4 2025 per PBH's latest filing, from $19.9 million in the prior quarter.
- Across five years, Operating Leases topped out at $24.5 million in Q4 2025 and bottomed at $6.1 million in Q4 2023.
- The 5-year median for Operating Leases is $16.9 million (2021), against an average of $16.2 million.
- Across the five-year window, Operating Leases plunged 65.81% in 2023 and surged 293.74% in 2024, its largest moves.
- Year by year, Operating Leases stood at $17.6 million in 2021, then slumped by 34.44% to $11.6 million in 2022, then sank by 46.9% to $6.1 million in 2023, then jumped by 293.74% to $24.2 million in 2024, then increased by 1.28% to $24.5 million in 2025.
- Per Business Quant, the three latest PBH Operating Leases figures stand at $24.5 million (Q4 2025), $19.9 million (Q3 2025), and $21.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.48 Mn |
| Sep 30, 2025 | 19.94 Mn |
| Jun 30, 2025 | 21.40 Mn |
| Mar 31, 2025 | 22.73 Mn |
| Dec 31, 2024 | 24.17 Mn |
| Sep 30, 2024 | 9.08 Mn |
| Jun 30, 2024 | 10.71 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | 6.14 Mn |
| Sep 30, 2023 | 6.64 Mn |
| Jun 30, 2023 | 14.82 Mn |
| Mar 31, 2023 | 9.88 Mn |
| Dec 31, 2022 | 11.56 Mn |
| Sep 30, 2022 | 19.43 Mn |
| Jun 30, 2022 | 14.46 Mn |
| Mar 31, 2022 | 16.09 Mn |
| Dec 31, 2021 | 17.63 Mn |
| Sep 30, 2021 | 24.08 Mn |
| Jun 30, 2021 | 24.30 Mn |
| Mar 31, 2021 | 19.71 Mn |